Ninoxan (Nitrous Oxide, Oxygen)

Nitrous oxide, the active ingredient in Ninoxan, is a gas anesthetic presented as an inhalation mixture of nitrous oxide and oxygen for inhalation use. It provides rapid analgesia and anxiolysis during short medical procedures, commonly employed in dental, minor surgical and obstetric settings.

GNH USA supplies Ninoxan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, dental clinics and obstetric centres worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Ninoxan, a nitrous oxide/oxygen inhalation mixture, is used for procedural analgesia and sedation across several clinical areas.

- Dental procedures: Provides rapid pain relief and anxiety reduction during restorative and surgical dental work. - Minor surgical procedures: Delivers analgesia and conscious sedation for short outpatient surgeries such as skin biopsies or orthopedic manipulations. - Labor and delivery: Offers inhalational analgesia to reduce pain and improve maternal comfort during childbirth.

Inhalation of nitrous oxide/oxygen can be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: Mild queasiness that may occur during or after inhalation. - Dizziness: Transient light‑headedness, especially on rapid ascent to higher concentrations. - Headache: Brief headache that resolves with discontinuation. - Euphoria: Temporary feeling of well‑being or giddiness. - Dry mouth: Reduced salivation during the procedure. - Fatigue: Mild tiredness after the session.

Serious or Rare Side Effects: - Hypoxia: Decreased blood oxygen levels if the oxygen fraction is insufficient. - Respiratory depression: Reduced breathing effort, particularly when combined with other depressants. - Loss of consciousness: Rare syncope if administered at high concentrations. - Severe vomiting: Risk of aspiration if vomiting occurs. - Allergic reaction: Rash, itching or anaphylaxis in sensitive individuals. - Methemoglobinemia: Rare blood disorder causing reduced oxygen delivery.

Safe administration of Ninoxan requires careful patient assessment and adherence to specific precautions. - Patient assessment: Evaluate respiratory function and contraindications before use. - Contraindications: Avoid in patients with known vitamin B12 deficiency or severe chronic obstructive pulmonary disease. - Monitoring: Continuously monitor oxygen saturation and level of consciousness during administration. - Caution with other depressants: Reduce dosage when used together with opioids, benzodiazepines or alcohol. - Duration limitation: Limit exposure to short procedures to prevent diffusion hypoxia. - Store at ambient temperature: Keep in original container, protect from moisture and direct sunlight.

Nitrous oxide may interact with several medications, altering their effects or increasing risk.

Major Interactions (Avoid): - Other central nervous system depressants: Concurrent use with opioids, benzodiazepines or barbiturates can cause profound respiratory depression. - Nitrites: Co‑administration may precipitate methemoglobinemia.

Moderate Interactions (Monitor Closely): - Alcohol: May enhance sedative effects, requiring dose adjustment. - MAO inhibitors: Potential for exaggerated cardiovascular responses. - Sedating antihistamines: Can increase drowsiness and impair psychomotor performance. - Anticholinergic agents: May affect airway secretions and increase risk of dry mouth. - Inhalational anesthetic gases: Combined use may lead to additive effects on ventilation.